Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Approves 1st New Schizophrenia Drug in Decades
FDA Approves the First New Schizophrenia Drug in Decades
No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric disorder.
The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment
The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated schizophrenia drug, Cobenfy. It’s the first novel treatment for the debilitating mental disorder in over seven decades.
Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking.
Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This drug takes the first new approach to schizophrenia treatment in decades,” the Food and Drug Administration said.
Medscape
33m
FDA OKs First-in-Class Antipsychotic for Schizophrenia
The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.
92.7 WMAY
55m
FDA approves first new drug for schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...
14h
FDA approves new schizophrenia drug
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Promotes watch collection
'Harry Potter' star dies
World's oldest cheese found
Killer gets life sentence
50/50 ball ownership suit
Ending password-sharing
Producing doc on Diddy
Boxes to distribute Narcan
Targeted Black residents?
Urgent safety alert for 737s
Stadiums to serve as shelters
Fake Biden robocalls fine
More executives leave
On Secret Service failures
Chinese submarine sank
NC board removes 747K
NIH finds misconduct
Arrives in Luxembourg
WI duplicate ballot flap
Rose announces retirement
Capital goods orders up
Military recruiting rebounds
RU hits Ukraine's power grid
Related topics
Food and Drug Administration
Bristol-Myers Squibb
Cobenfy
Feedback